Scholars Central

Conference abstractPublished 2 Nov 2017

A high throughput platform for the identiÞ cation of inhibitors of integrin-mediated TGF􀁅 activation

Authors: Ruihua Chen

Bristol-Myers Squibb Company, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Integrins and Transforming Growth Factor beta (TGFβ) regulate multiple cellular processes including adhesion, migration, proliferation, extracellular matrix (ECM) homeostasis and epithelial-mesenchymal transition. Integrin–mediated TGFβ activation has been indicated in pathological conditions including fibrogenesis and immune suppression. Macrophages are a major cellular source of TGFβ. Alteration of macrophage phenotypes and aberrant activation of TGFβ lead to several fibrotic and immune diseases therefore inhibitors of TGF-β activation have potential values in multiple therapeutic areas. We have developed de novo Homogenous Time Resolved Fluorescence 1536-well binding assays using multiple integrins to identify inhibitors and to support mechanism of action studies. Further, we have developed a high throughput Detroit 562 cell co-culture assay to measure TGFβ activation. In conjunction with these studies, we have also utilized a macrophage polarization model and developed cytokine and mRNA profiling assays to explore potential pharmacodynamic and/or disease biomarkers. These studies offer a novel platform to identify novel inhibitors of TGF beta signaling associated with specific subsets of integrins.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectSocial Sciences & Humanities
  • BylineArticles whose byline prints “Ruihua Chen”